• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global Equine Pharmaceuticals and Supplements Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026

report cover
  • 2 September 2020
  • Healthcare
  • 113 Pages
  • Report Code: 24LS-21323
  • Formate :   
Download FREE Report Sample Download PDF File

Equine Pharmaceuticals Supplements -MARKET ADVISORY SERVICES

Equine Pharmaceuticals and Supplements market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Equine Pharmaceuticals and Supplements market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2015-2026.

Segment by Type, the Equine Pharmaceuticals and Supplements market is segmented into
Pharmaceuticals
Supplements

Segment by Application, the Equine Pharmaceuticals and Supplements market is segmented into
Thoroughbred Horse
Other Types of Horses

Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Competitive Landscape and Equine Pharmaceuticals and Supplements Market Share Analysis
Equine Pharmaceuticals and Supplements market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2015-2020. Details included are company description, major business, Equine Pharmaceuticals and Supplements product introduction, recent developments, Equine Pharmaceuticals and Supplements sales by region, type, application and by sales channel.

The major companies include:
Boehringer Ingelheim
Merck Animal Health
Zoetis
Bayer Animal Health
Elanco Animal Health
Dechra Veterinary Products
CEVA
Virbac
Norbrook Equine
Kyoritsu Seiyaku
Vetoquinol
Protexin Healthcare
Audevard
Ouro Fino Saude
1 Study Coverage
1.1 Equine Pharmaceuticals and Supplements Product Introduction
1.2 Market by Type
1.2.1 Global Equine Pharmaceuticals and Supplements Market Size Growth Rate by Type
1.2.2 Pharmaceuticals
1.2.3 Supplements
1.3 Market by Application
1.3.1 Global Equine Pharmaceuticals and Supplements Market Size Growth Rate by Application
1.3.2 Thoroughbred Horse
1.3.3 Other Types of Horses
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Equine Pharmaceuticals and Supplements Market Size Estimates and Forecasts
2.1.1 Global Equine Pharmaceuticals and Supplements Revenue 2015-2026
2.1.2 Global Equine Pharmaceuticals and Supplements Sales 2015-2026
2.2 Equine Pharmaceuticals and Supplements Market Size by Region: 2020 Versus 2026
2.3 Equine Pharmaceuticals and Supplements Sales by Region (2015-2026)
2.3.1 Global Equine Pharmaceuticals and Supplements Sales by Region: 2015-2020
2.3.2 Global Equine Pharmaceuticals and Supplements Sales Forecast by Region (2021-2026)
2.3.3 Global Equine Pharmaceuticals and Supplements Sales Market Share by Region (2015-2026)
2.4 Equine Pharmaceuticals and Supplements Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Equine Pharmaceuticals and Supplements Revenue by Region: 2015-2020
2.4.2 Global Equine Pharmaceuticals and Supplements Revenue Forecast by Region (2021-2026)
2.4.3 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2015-2026)

3 Global Equine Pharmaceuticals and Supplements by Manufacturers
3.1 Global Top Equine Pharmaceuticals and Supplements Manufacturers by Sales
3.1.1 Global Equine Pharmaceuticals and Supplements Sales by Manufacturer (2015-2020)
3.1.2 Global Equine Pharmaceuticals and Supplements Sales Market Share by Manufacturer (2015-2019)
3.2 Global Top Equine Pharmaceuticals and Supplements Manufacturers by Revenue
3.2.1 Global Equine Pharmaceuticals and Supplements Revenue by Manufacturer (2015-2020)
3.2.2 Global Equine Pharmaceuticals and Supplements Revenue Share by Manufacturer (2015-2020)
3.3 Global Equine Pharmaceuticals and Supplements Price by Manufacturer (2015-2020)
3.4 Competitive Landscape
3.4.1 Key Equine Pharmaceuticals and Supplements Manufacturers Covered: Ranking by Revenue
3.4.2 Global Equine Pharmaceuticals and Supplements Market Concentration Ratio (CR5 and HHI) & (2015-2020)
3.4.3 Global Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Equine Pharmaceuticals and Supplements Manufacturing Base Distribution, Product Type
3.5.1 Equine Pharmaceuticals and Supplements Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Equine Pharmaceuticals and Supplements Product Type
3.5.3 Date of International Manufacturers Enter into Equine Pharmaceuticals and Supplements Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles
4.1 Boehringer Ingelheim
4.1.1 Boehringer Ingelheim Corporation Information
4.1.2 Boehringer Ingelheim Description, Business Overview
4.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Products Offered
4.1.4 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
4.1.5 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Revenue by Product
4.1.6 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Revenue by Application
4.1.7 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.1.8 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Revenue by Sales Channel
4.1.9 Boehringer Ingelheim Recent Development
4.2 Merck Animal Health
4.2.1 Merck Animal Health Corporation Information
4.2.2 Merck Animal Health Description, Business Overview
4.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Products Offered
4.2.4 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
4.2.5 Merck Animal Health Equine Pharmaceuticals and Supplements Revenue by Product
4.2.6 Merck Animal Health Equine Pharmaceuticals and Supplements Revenue by Application
4.2.7 Merck Animal Health Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.2.8 Merck Animal Health Equine Pharmaceuticals and Supplements Revenue by Sales Channel
4.2.9 Merck Animal Health Recent Development
4.3 Zoetis
4.3.1 Zoetis Corporation Information
4.3.2 Zoetis Description, Business Overview
4.3.3 Zoetis Equine Pharmaceuticals and Supplements Products Offered
4.3.4 Zoetis Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
4.3.5 Zoetis Equine Pharmaceuticals and Supplements Revenue by Product
4.3.6 Zoetis Equine Pharmaceuticals and Supplements Revenue by Application
4.3.7 Zoetis Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.3.8 Zoetis Equine Pharmaceuticals and Supplements Revenue by Sales Channel
4.3.9 Zoetis Recent Development
4.4 Bayer Animal Health
4.4.1 Bayer Animal Health Corporation Information
4.4.2 Bayer Animal Health Description, Business Overview
4.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Products Offered
4.4.4 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
4.4.5 Bayer Animal Health Equine Pharmaceuticals and Supplements Revenue by Product
4.4.6 Bayer Animal Health Equine Pharmaceuticals and Supplements Revenue by Application
4.4.7 Bayer Animal Health Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.4.8 Bayer Animal Health Equine Pharmaceuticals and Supplements Revenue by Sales Channel
4.4.9 Bayer Animal Health Recent Development
4.5 Elanco Animal Health
4.5.1 Elanco Animal Health Corporation Information
4.5.2 Elanco Animal Health Description, Business Overview
4.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Products Offered
4.5.4 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
4.5.5 Elanco Animal Health Equine Pharmaceuticals and Supplements Revenue by Product
4.5.6 Elanco Animal Health Equine Pharmaceuticals and Supplements Revenue by Application
4.5.7 Elanco Animal Health Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.5.8 Elanco Animal Health Equine Pharmaceuticals and Supplements Revenue by Sales Channel
4.5.9 Elanco Animal Health Recent Development
4.6 Dechra Veterinary Products
4.6.1 Dechra Veterinary Products Corporation Information
4.6.2 Dechra Veterinary Products Description, Business Overview
4.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Products Offered
4.6.4 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
4.6.5 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Revenue by Product
4.6.6 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Revenue by Application
4.6.7 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.6.8 Dechra Veterinary Products Recent Development
4.7 CEVA
4.7.1 CEVA Corporation Information
4.7.2 CEVA Description, Business Overview
4.7.3 CEVA Equine Pharmaceuticals and Supplements Products Offered
4.7.4 CEVA Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
4.7.5 CEVA Equine Pharmaceuticals and Supplements Revenue by Product
4.7.6 CEVA Equine Pharmaceuticals and Supplements Revenue by Application
4.7.7 CEVA Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.7.8 CEVA Recent Development
4.8 Virbac
4.8.1 Virbac Corporation Information
4.8.2 Virbac Description, Business Overview
4.8.3 Virbac Equine Pharmaceuticals and Supplements Products Offered
4.8.4 Virbac Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
4.8.5 Virbac Equine Pharmaceuticals and Supplements Revenue by Product
4.8.6 Virbac Equine Pharmaceuticals and Supplements Revenue by Application
4.8.7 Virbac Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.8.8 Virbac Recent Development
4.9 Norbrook Equine
4.9.1 Norbrook Equine Corporation Information
4.9.2 Norbrook Equine Description, Business Overview
4.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Products Offered
4.9.4 Norbrook Equine Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
4.9.5 Norbrook Equine Equine Pharmaceuticals and Supplements Revenue by Product
4.9.6 Norbrook Equine Equine Pharmaceuticals and Supplements Revenue by Application
4.9.7 Norbrook Equine Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.9.8 Norbrook Equine Recent Development
4.10 Kyoritsu Seiyaku
4.10.1 Kyoritsu Seiyaku Corporation Information
4.10.2 Kyoritsu Seiyaku Description, Business Overview
4.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Products Offered
4.10.4 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
4.10.5 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Revenue by Product
4.10.6 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Revenue by Application
4.10.7 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.10.8 Kyoritsu Seiyaku Recent Development
4.11 Vetoquinol
4.11.1 Vetoquinol Corporation Information
4.11.2 Vetoquinol Description, Business Overview
4.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Products Offered
4.11.4 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
4.11.5 Vetoquinol Equine Pharmaceuticals and Supplements Revenue by Product
4.11.6 Vetoquinol Equine Pharmaceuticals and Supplements Revenue by Application
4.11.7 Vetoquinol Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.11.8 Vetoquinol Recent Development
4.12 Protexin Healthcare
4.12.1 Protexin Healthcare Corporation Information
4.12.2 Protexin Healthcare Description, Business Overview
4.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Products Offered
4.12.4 Protexin Healthcare Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
4.12.5 Protexin Healthcare Equine Pharmaceuticals and Supplements Revenue by Product
4.12.6 Protexin Healthcare Equine Pharmaceuticals and Supplements Revenue by Application
4.12.7 Protexin Healthcare Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.12.8 Protexin Healthcare Recent Development
4.13 Audevard
4.13.1 Audevard Corporation Information
4.13.2 Audevard Description, Business Overview
4.13.3 Audevard Equine Pharmaceuticals and Supplements Products Offered
4.13.4 Audevard Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
4.13.5 Audevard Equine Pharmaceuticals and Supplements Revenue by Product
4.13.6 Audevard Equine Pharmaceuticals and Supplements Revenue by Application
4.13.7 Audevard Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.13.8 Audevard Recent Development
4.14 Ouro Fino Saude
4.14.1 Ouro Fino Saude Corporation Information
4.14.2 Ouro Fino Saude Description, Business Overview
4.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Products Offered
4.14.4 Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales, Revenue and Gross Margin (2015-2020)
4.14.5 Ouro Fino Saude Equine Pharmaceuticals and Supplements Revenue by Product
4.14.6 Ouro Fino Saude Equine Pharmaceuticals and Supplements Revenue by Application
4.14.7 Ouro Fino Saude Equine Pharmaceuticals and Supplements Revenue by Geographic Area
4.14.8 Ouro Fino Saude Recent Development

5 Breakdown Data by Type
5.1 Global Equine Pharmaceuticals and Supplements Sales by Type (2015-2026)
5.1.1 Global Equine Pharmaceuticals and Supplements Sales by Type (2015-2020)
5.1.2 Global Equine Pharmaceuticals and Supplements Sales Forecast by Type (2021-2026)
5.1.3 Global Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2026)
5.2 Global Equine Pharmaceuticals and Supplements Revenue Forecast by Type (2015-2026)
5.2.1 Global Equine Pharmaceuticals and Supplements Revenue by Type (2015-2020)
5.2.2 Global Equine Pharmaceuticals and Supplements Revenue Forecast by Type (2021-2026)
5.2.3 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Type (2015-2026)
5.3 Equine Pharmaceuticals and Supplements Average Selling Price (ASP) by Type (2015-2026)
6 Breakdown Data by Application
6.1 Global Equine Pharmaceuticals and Supplements Sales by Application (2015-2026)
6.1.1 Global Equine Pharmaceuticals and Supplements Sales by Application (2015-2020)
6.1.2 Global Equine Pharmaceuticals and Supplements Sales Forecast by Application (2021-2026)
6.1.3 Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2015-2026)
6.2 Global Equine Pharmaceuticals and Supplements Revenue Forecast by Application (2015-2026)
6.2.1 Global Equine Pharmaceuticals and Supplements Revenue by Application (2015-2020)
6.2.2 Global Equine Pharmaceuticals and Supplements Revenue Forecast by Application (2021-2026)
6.2.3 Global Equine Pharmaceuticals and Supplements Revenue Market Share by Application (2015-2026)
6.3 Equine Pharmaceuticals and Supplements Average Selling Price (ASP) by Application (2015-2026)

7 North America
7.1 North America Equine Pharmaceuticals and Supplements Market Size YoY Growth 2015-2026
7.2 North America Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
7.2.1 North America Equine Pharmaceuticals and Supplements Sales by Country (2015-2026)
7.2.2 North America Equine Pharmaceuticals and Supplements Revenue by Country (2015-2026)
7.3 North America Equine Pharmaceuticals and Supplements Sales by Type
7.4 North America Equine Pharmaceuticals and Supplements Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Equine Pharmaceuticals and Supplements Market Size YoY Growth 2015-2026
8.2 Asia-Pacific Equine Pharmaceuticals and Supplements Market Facts & Figures by Region
8.2.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Region (2015-2026)
8.2.2 Asia-Pacific Equine Pharmaceuticals and Supplements Revenue by Region (2015-2026)
8.3 Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Type
8.4 Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Application
9 Europe
9.1 Europe Equine Pharmaceuticals and Supplements Market Size YoY Growth 2015-2026
9.2 Europe Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
9.2.1 Europe Equine Pharmaceuticals and Supplements Sales by Country (2015-2026)
9.2.2 Europe Equine Pharmaceuticals and Supplements Revenue by Country (2015-2026)
9.3 Europe Equine Pharmaceuticals and Supplements Sales by Type
9.4 Europe Equine Pharmaceuticals and Supplements Sales by Application
10 Latin America
10.1 Latin America Equine Pharmaceuticals and Supplements Market Size YoY Growth 2015-2026
10.2 Latin America Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
10.2.1 Latin America Equine Pharmaceuticals and Supplements Sales by Country (2015-2026)
10.2.2 Latin America Equine Pharmaceuticals and Supplements Revenue by Country (2015-2026)
10.3 Latin America Equine Pharmaceuticals and Supplements Sales by Type
10.4 Latin America Equine Pharmaceuticals and Supplements Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Equine Pharmaceuticals and Supplements Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Equine Pharmaceuticals and Supplements Market Facts & Figures by Country
11.2.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2015-2026)
11.2.2 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country (2015-2026)
11.3 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Type
11.4 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Equine Pharmaceuticals and Supplements Supply Chain Analysis
12.2 Equine Pharmaceuticals and Supplements Key Raw Materials and Upstream Suppliers
12.3 Equine Pharmaceuticals and Supplements Clients Analysis
12.4 Equine Pharmaceuticals and Supplements Sales Channel and Sales Model Analysis
12.4.1 Equine Pharmaceuticals and Supplements Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Equine Pharmaceuticals and Supplements Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Equine Pharmaceuticals and Supplements Distributors
13 Market Dynamics
13.1 Equine Pharmaceuticals and Supplements Market Drivers
13.2 Equine Pharmaceuticals and Supplements Market Opportunities
13.3 Equine Pharmaceuticals and Supplements Market Challenges
13.4 Equine Pharmaceuticals and Supplements Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables

Table 1. Global Equine Pharmaceuticals and Supplements Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 2. Major Manufacturers of Pharmaceuticals

Table 3. Major Manufacturers of Supplements

Table 4. Global Equine Pharmaceuticals and Supplements Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 5. Global Equine Pharmaceuticals and Supplements Market Size by Region (US$ Million): 2020 VS 2026

Table 6. Global Equine Pharmaceuticals and Supplements Sales by Region (2015-2020) & (K Units)

Table 7. Global Equine Pharmaceuticals and Supplements Sales Forecast by Region (2021-2026) & (K Units)

Table 8. Global Equine Pharmaceuticals and Supplements Revenue by Region (2015-2020) & (US$ Million)

Table 9. Global Equine Pharmaceuticals and Supplements Revenue Forecast by Region (2021-2026) & (US$ Million)

Table 10. Global Equine Pharmaceuticals and Supplements Sales by Manufacturer (2015-2020) & (K Units)

Table 11. Global Equine Pharmaceuticals and Supplements Sales Share by Manufacturer (2015-2020)

Table 12. Equine Pharmaceuticals and Supplements Revenue by Manufacturer (2015-2020) & (US$ Million)

Table 13. Equine Pharmaceuticals and Supplements Revenue Share by Manufacturer (2015-2020)

Table 14. Key Manufacturers Equine Pharmaceuticals and Supplements Price (2015-2020) & (USD/Unit)

Table 15. Ranking of Global Top Equine Pharmaceuticals and Supplements Manufacturers by Revenue (US$ Million) in 2019

Table 16. Global Equine Pharmaceuticals and Supplements Manufacturers Market Concentration Ratio (CR5 and HHI) & (2015-2020)

Table 17. Global Equine Pharmaceuticals and Supplements by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Equine Pharmaceuticals and Supplements as of 2019)

Table 18. Equine Pharmaceuticals and Supplements Manufacturers Manufacturing Base Distribution and Headquarters

Table 19. Manufacturers Equine Pharmaceuticals and Supplements Product Type

Table 20. Date of International Manufacturers Enter into Equine Pharmaceuticals and Supplements Market

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Boehringer Ingelheim Corporation Information

Table 23. Boehringer Ingelheim Description and Business Overview

Table 24. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 25. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product

Table 26. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product

Table 27. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application

Table 28. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area

Table 29. Boehringer Ingelheim Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Sales Channel

Table 30. Boehringer Ingelheim Recent Development

Table 31. Merck Animal Health Corporation Information

Table 32. Merck Animal Health Description and Business Overview

Table 33. Merck Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 34. Merck Animal Health Equine Pharmaceuticals and Supplements Product

Table 35. Merck Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product

Table 36. Merck Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application

Table 37. Merck Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area

Table 38. Merck Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Sales Channel

Table 39. Merck Animal Health Recent Development

Table 40. Zoetis Corporation Information

Table 41. Zoetis Description and Business Overview

Table 42. Zoetis Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 43. Zoetis Equine Pharmaceuticals and Supplements Product

Table 44. Zoetis Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product

Table 45. Zoetis Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application

Table 46. Zoetis Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area

Table 47. Zoetis Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Sales Channel

Table 48. Zoetis Recent Development

Table 49. Bayer Animal Health Corporation Information

Table 50. Bayer Animal Health Description and Business Overview

Table 51. Bayer Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 52. Bayer Animal Health Equine Pharmaceuticals and Supplements Product

Table 53. Bayer Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product

Table 54. Bayer Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application

Table 55. Bayer Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area

Table 56. Bayer Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Sales Channel

Table 57. Bayer Animal Health Recent Development

Table 58. Elanco Animal Health Corporation Information

Table 59. Elanco Animal Health Description and Business Overview

Table 60. Elanco Animal Health Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 61. Elanco Animal Health Equine Pharmaceuticals and Supplements Product

Table 62. Elanco Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product

Table 63. Elanco Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application

Table 64. Elanco Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area

Table 65. Elanco Animal Health Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Sales Channel

Table 66. Elanco Animal Health Recent Development

Table 67. Dechra Veterinary Products Corporation Information

Table 68. Dechra Veterinary Products Description and Business Overview

Table 69. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 70. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product

Table 71. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product

Table 72. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application

Table 73. Dechra Veterinary Products Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area

Table 74. Dechra Veterinary Products Recent Development

Table 75. CEVA Corporation Information

Table 76. CEVA Description and Business Overview

Table 77. CEVA Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 78. CEVA Equine Pharmaceuticals and Supplements Product

Table 79. CEVA Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product

Table 80. CEVA Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application

Table 81. CEVA Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area

Table 82. CEVA Recent Development

Table 83. Virbac Corporation Information

Table 84. Virbac Description and Business Overview

Table 85. Virbac Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 86. Virbac Equine Pharmaceuticals and Supplements Product

Table 87. Virbac Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product

Table 88. Virbac Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application

Table 89. Virbac Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area

Table 90. Virbac Recent Development

Table 91. Norbrook Equine Corporation Information

Table 92. Norbrook Equine Description and Business Overview

Table 93. Norbrook Equine Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 94. Norbrook Equine Equine Pharmaceuticals and Supplements Product

Table 95. Norbrook Equine Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product

Table 96. Norbrook Equine Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application

Table 97. Norbrook Equine Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area

Table 98. Norbrook Equine Recent Development

Table 99. Kyoritsu Seiyaku Corporation Information

Table 100. Kyoritsu Seiyaku Description and Business Overview

Table 101. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 102. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product

Table 103. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product

Table 104. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application

Table 105. Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area

Table 106. Kyoritsu Seiyaku Recent Development

Table 107. Vetoquinol Corporation Information

Table 108. Vetoquinol Description and Business Overview

Table 109. Vetoquinol Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 110. Vetoquinol Equine Pharmaceuticals and Supplements Product

Table 111. Vetoquinol Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product

Table 112. Vetoquinol Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application

Table 113. Vetoquinol Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area

Table 114. Vetoquinol Recent Development

Table 115. Protexin Healthcare Corporation Information

Table 116. Protexin Healthcare Description and Business Overview

Table 117. Protexin Healthcare Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 118. Protexin Healthcare Equine Pharmaceuticals and Supplements Product

Table 119. Protexin Healthcare Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product

Table 120. Protexin Healthcare Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application

Table 121. Protexin Healthcare Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area

Table 122. Protexin Healthcare Recent Development

Table 123. Audevard Corporation Information

Table 124. Audevard Description and Business Overview

Table 125. Audevard Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 126. Audevard Equine Pharmaceuticals and Supplements Product

Table 127. Audevard Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product

Table 128. Audevard Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application

Table 129. Audevard Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area

Table 130. Audevard Recent Development

Table 131. Ouro Fino Saude Corporation Information

Table 132. Ouro Fino Saude Description and Business Overview

Table 133. Ouro Fino Saude Equine Pharmaceuticals and Supplements Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 134. Ouro Fino Saude Equine Pharmaceuticals and Supplements Product

Table 135. Ouro Fino Saude Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Product

Table 136. Ouro Fino Saude Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Application

Table 137. Ouro Fino Saude Equine Pharmaceuticals and Supplements Revenue (US$ Million) and Market Share by Geographic Area

Table 138. Ouro Fino Saude Recent Development

Table 139. Global Equine Pharmaceuticals and Supplements Sales by Type (2015-2020) & (K Units)

Table 140. Global Equine Pharmaceuticals and Supplements Sales Forecast by Type (2021-2026) & (K Units)

Table 141. Global Equine Pharmaceuticals and Supplements Revenue by Type (2015-2020) & (US$ Million)

Table 142. Global Equine Pharmaceuticals and Supplements Revenue Forecast by Type (2021-2026) & (US$ Million)

Table 143. Global Equine Pharmaceuticals and Supplements Sales by Application (2015-2020) & (K Units)

Table 144. Global Equine Pharmaceuticals and Supplements Sales Forecast by Application (2021-2026) & (K Units)

Table 145. Global Equine Pharmaceuticals and Supplements Revenue by Application (2015-2020) & (US$ Million)

Table 146. Global Equine Pharmaceuticals and Supplements Revenue Forecast by Application (2021-2026) & (US$ Million)

Table 147. North America Equine Pharmaceuticals and Supplements Sales by Country (2015-2020) & (K Units)

Table 148. North America Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units)

Table 149. North America Equine Pharmaceuticals and Supplements Revenue by Country (2015-2020) & (US$ Million)

Table 150. North America Equine Pharmaceuticals and Supplements Revenue by Country (2021-2026) & (US$ Million)

Table 151. North America Equine Pharmaceuticals and Supplements Sales by Type (2015-2020) & (K Units)

Table 152. North America Equine Pharmaceuticals and Supplements Sales by Application (2015-2020) & (K Units)

Table 153. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Region (2015-2020) & (K Units)

Table 154. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Region (2021-2026) & (K Units)

Table 155. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue by Region (2015-2026) & (US$ Million)

Table 156. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue by Region (2021-2026) & (US$ Million)

Table 157. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Type (2015-2020) & (K Units)

Table 158. Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Application (2015-2020) & (K Units)

Table 159. Europe Equine Pharmaceuticals and Supplements Sales by Country (2015-2020) & (K Units)

Table 160. Europe Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units)

Table 161. Europe Equine Pharmaceuticals and Supplements Revenue by Country (2015-2020) & (US$ Million)

Table 162. Europe Equine Pharmaceuticals and Supplements Revenue by Country (2021-2026) & (US$ Million)

Table 163. Europe Equine Pharmaceuticals and Supplements Sales by Type (2015-2020) & (K Units)

Table 164. Europe Equine Pharmaceuticals and Supplements Sales by Application (2015-2020) & (K Units)

Table 165. Latin America Equine Pharmaceuticals and Supplements Sales by Country (2015-2020) & (K Units)

Table 166. Latin America Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units)

Table 167. Latin America Equine Pharmaceuticals and Supplements Revenue by Country (2015-2020) & (US$ Million)

Table 168. Latin America Equine Pharmaceuticals and Supplements Revenue by Country (2021-2026) & (US$ Million)

Table 169. Latin America Equine Pharmaceuticals and Supplements Sales by Type (2015-2020) & (K Units)

Table 170. Latin America Equine Pharmaceuticals and Supplements Sales by Application (2015-2020) & (K Units)

Table 171. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2015-2020) & (K Units)

Table 172. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Country (2021-2026) & (K Units)

Table 173. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country (2015-2020) & (US$ Million)

Table 174. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Country (2021-2026) & (US$ Million)

Table 175. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Type (2015-2020) & (K Units)

Table 176. Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Application (2015-2020) & (K Units)

Table 177. Equine Pharmaceuticals and Supplements Key Raw Materials, Industry Status and Trend

Table 178. Equine Pharmaceuticals and Supplements Key Raw Materials and Upstream Suppliers

Table 179. Equine Pharmaceuticals and Supplements Clients Status and Trend

Table 180. Equine Pharmaceuticals and Supplements Typical Clients

Table 181. Equine Pharmaceuticals and Supplements Distributors

Table 182. Key Drivers: Impact Analysis (2021-2026)

Table 183. Equine Pharmaceuticals and Supplements Market Drivers

Table 184. Equine Pharmaceuticals and Supplements Market Opportunities

Table 185. Equine Pharmaceuticals and Supplements Market Challenges

Table 186. Equine Pharmaceuticals and Supplements Market Restraints

Table 187. Equine Pharmaceuticals and Supplements Porter?s Five Forces Analysis

Table 188. Research Programs/Design for This Report

Table 189. Key Data Information from Secondary Sources

Table 190. Key Data Information from Primary Sources

List of Figures

Figure 1. Equine Pharmaceuticals and Supplements Product Picture

Figure 2. Global Equine Pharmaceuticals and Supplements Sales Market Share by Type in 2020 & 2026

Figure 3. Pharmaceuticals Product Picture

Figure 4. Supplements Product Picture

Figure 5. Global Equine Pharmaceuticals and Supplements Sales Market Share by Application in 2020 & 2026

Figure 6. Thoroughbred Horse Examples

Figure 7. Other Types of Horses Examples

Figure 8. Equine Pharmaceuticals and Supplements Report Years Considered

Figure 9. Global Equine Pharmaceuticals and Supplements Market Size, (US$ Million), 2015 VS 2020 VS 2026

Figure 10. Global Equine Pharmaceuticals and Supplements Market Size 2015-2026 (US$ Million)

Figure 11. Global Equine Pharmaceuticals and Supplements Sales 2015-2026 (K Units)

Figure 12. Global Equine Pharmaceuticals and Supplements Market Size Market Share by Region: 2020 Versus 2026

Figure 13. Global Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Region (2015-2026)

Figure 14. Global Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2015-2026)

Figure 15. Global Equine Pharmaceuticals and Supplements Sales Share by Manufacturer in 2019

Figure 16. Equine Pharmaceuticals and Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 17. Global Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Type (2015-2026)

Figure 18. Global Equine Pharmaceuticals and Supplements Revenue Market Share Forecast by Type (2015-2026)

Figure 19. Equine Pharmaceuticals and Supplements Average Selling Price (ASP) by Type (2015-2020) & (USD/Unit)

Figure 20. Global Equine Pharmaceuticals and Supplements Sales Market Share Forecast by Application (2015-2026)

Figure 21. Global Equine Pharmaceuticals and Supplements Revenue Market Share Forecast by Application (2015-2026)

Figure 22. Equine Pharmaceuticals and Supplements Average Selling Price (ASP) by Application (2015-2020) & (USD/Unit)

Figure 23. North America Equine Pharmaceuticals and Supplements Revenue 2015-2026 (US$ Million)

Figure 24. North America Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)

Figure 25. North America Equine Pharmaceuticals and Supplements Sales Market Share by Application (2015-2020)

Figure 26. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue 2015-2026 (US$ Million)

Figure 27. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Region (2015-2026)

Figure 28. Asia-Pacific Equine Pharmaceuticals and Supplements Revenue Market Share by Region (2015-2026)

Figure 29. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)

Figure 30. Asia-Pacific Equine Pharmaceuticals and Supplements Sales Market Share by Application (2015-2020)

Figure 31. Europe Equine Pharmaceuticals and Supplements Revenue Growth Rate 2015-2026 (US$ Million)

Figure 32. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Country (2015-2026)

Figure 33. Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2015-2026)

Figure 34. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)

Figure 35. Europe Equine Pharmaceuticals and Supplements Sales Market Share by Application (2015-2020)

Figure 36. Latin America Equine Pharmaceuticals and Supplements Revenue Growth Rate 2015-2026 (US$ Million)

Figure 37. Latin America Equine Pharmaceuticals and Supplements Sales Market Share by Country (2015-2026)

Figure 38. Latin America Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2015-2020)

Figure 39. Latin America Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)

Figure 40. Latin America Equine Pharmaceuticals and Supplements Sales Market Share by Application (2015-2020)

Figure 41. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue Growth Rate 2015-2026 (US$ Million)

Figure 42. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Country (2015-2026)

Figure 43. Middle East and Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Country (2015-2026)

Figure 44. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Type (2015-2020)

Figure 45. Middle East and Africa Equine Pharmaceuticals and Supplements Sales Market Share by Application (2015-2020)

Figure 46. Equine Pharmaceuticals and Supplements Supply Chain (Upstream and Downstream Market)

Figure 47. Global Production Market Share of Equine Pharmaceuticals and Supplements Raw Materials by Region in 2019

Figure 48. Equine Pharmaceuticals and Supplements Distribution Channels

Figure 49. Global Equine Pharmaceuticals and Supplements Percentage 2015-2026: Indirect Sales VS Direct Sales

Figure 50. Global Equine Pharmaceuticals and Supplements Percentage 2015-2026: Online Sales VS Offline Sales

Figure 51. Porter's Five Forces Analysis

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

Boehringer Ingelheim

Merck Animal Health

Zoetis

Bayer Animal Health

Elanco Animal Health

Dechra Veterinary Products

CEVA

Virbac

Norbrook Equine

Kyoritsu Seiyaku

Vetoquinol

Protexin Healthcare

Audevard

Ouro Fino Saude

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $4425

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase